Want to see XERS full AI Analyst Report?
Xeris Pharmaceuticals (XERS) Ownership - Who Owns Xeris Pharmaceuticals?
1,113 Followers
Xeris Pharmaceuticals (XERS) Ownership Overview
- 4.91% Insiders
- 12.20% Mutual Funds
- 1.13% Other Institutional Investors
- 14.10% ETFs
- 67.66% Public Companies and Individual Investors
The ownership structure of Xeris Pharmaceuticals (XERS) stock is a mix of institutional, retail, and individual investors. Approximately 27.43% of the company’s stock is owned by Institutional Investors, 4.91% is owned by Insiders, and 67.66% is owned by Public Companies and Individual Investors.
The ownership structure of Xeris Pharmaceuticals (XERS) stock is a mix of institutional, retail, and individual investors. Approximately 27.43% of the company’s stock is owned by Institutional Investors, 4.91% is owned by Insiders, and 67.66% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
| Date | Name | Activity | Value |
|---|---|---|---|
| Dec 18, 2025 | John Johnson | $976,234 |
Recent Hedge Fund Trading Activity
| Date | Firm | Activity | Value |
|---|---|---|---|
| Jun 30, 2026 | Graham Capital Management, L.p. | $128,827 | |
| Jun 30, 2026 | Entrypoint Capital, Llc | $639,540 | |
| Jun 30, 2026 | $115,042,269 | ||
| Jun 30, 2026 | Royce & Associates Llc | $3,652,332 |
Top Shareholders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| BlackRock, Inc. | 14,525,539 | Institution | 7.97% | 150,339,329 |
| Vanguard | 9,266,573 | Institution | 5.08% | 95,909,031 |
| Ishares | 7,935,665 | Institution | 4.35% | 82,134,133 |
| Vanguard Index Funds | 7,180,117 | Institution | 3.94% | 74,314,211 |
| John Patrick Shannon | 2,898,933 | Insider | 1.59% | 30,003,957 |
| Tiaa-cref Funds | 2,731,436 | Institution | 1.50% | 28,270,363 |
| Fidelity Salem Street Trust | 2,055,229 | Institution | 1.13% | 21,271,620 |
| Spdr | 1,851,521 | Institution | 1.02% | 19,163,242 |
| Fidelity Concord Street Trust | 1,769,397 | Institution | 0.97% | 18,313,259 |
| Kevin Mcculloch | 1,639,208 | Insider | 0.90% | 16,965,803 |
Top Mutual Fund Holders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Vanguard Index Funds | 7,180,117 | Institution | 3.94% | 74,314,211 |
| Tiaa-cref Funds | 2,731,436 | Institution | 1.50% | 28,270,363 |
| Fidelity Salem Street Trust | 2,055,229 | Institution | 1.13% | 21,271,620 |
| Fidelity Concord Street Trust | 1,769,397 | Institution | 0.97% | 18,313,259 |
| Vanguard Scottsdale Funds | 1,183,316 | Institution | 0.65% | 12,247,321 |
| Federated Hermes Mdt Series | 1,067,305 | Institution | 0.59% | 11,046,607 |
| Schwab Capital Trust | 577,876 | Institution | 0.32% | 5,981,017 |
| Dfa Investment Dimensions Group Inc | 530,141 | Institution | 0.29% | 5,486,959 |
| Vanguard World Fund | 514,791 | Institution | 0.28% | 5,328,087 |
| Vanguard Explorer Fund | 490,039 | Institution | 0.27% | 5,071,904 |
Top ETF Holders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Vanguard, VTI ETF | 5,501,446 | Institution | 3.02% | 52,593,824 |
| iShares, IWM ETF | 4,354,833 | Institution | 2.39% | 45,072,522 |
| Vanguard, VXF ETF | 2,048,248 | Institution | 1.12% | 19,581,251 |
| iShares, IWO ETF | 1,618,162 | Institution | 0.89% | 16,747,977 |
| SPDR, XPH ETF | 1,208,032 | Institution | 0.66% | 12,285,685 |
| Fidelity, FESM ETF | 1,137,751 | Institution | 0.62% | 11,570,928 |
| Vanguard, VTWO ETF | 996,866 | Institution | 0.55% | 9,530,039 |
| Schwab, SCHA ETF | 969,762 | Institution | 0.53% | 9,862,480 |
| First Trust, FYC ETF | 905,849 | Institution | 0.50% | 9,375,537 |
| DFA, DFAS ETF | 745,664 | Institution | 0.41% | 7,583,403 |
FAQ
Who Owns Xeris Pharmaceuticals (XERS)?
According to the latest TipRanks data, approximately 27.43% of the company's stock is held by institutional investors, 4.91% is held by insiders, and 67.66% is held by public companies and individual investors.
What percentage of Xeris Pharmaceuticals (XERS) stock is held by institutional investors?
According to the latest TipRanks data, approximately 27.43% of Xeris Pharmaceuticals (XERS) stock is held by institutional investors: 12.20% by mutual funds, 14.10% by ETFs and 1.13% by other institutional investors.
What percentage of Xeris Pharmaceuticals (XERS) stock is held by retail investors?
According to the latest TipRanks data, approximately 67.66% of Xeris Pharmaceuticals (XERS) stock is held by public companies and individual investors.
Who owns the most shares of Xeris Pharmaceuticals (XERS)?
BlackRock, Inc. owns the most shares of Xeris Pharmaceuticals (XERS).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
